Seeing Is Believing
Healthcare - Sector
HALO is currently covered by 9 analysts with an average price target of $78.35. This is a potential upside of -$32.05 (-29.03%) from yesterday's end of day stock price of $110.4.
Halozyme Therapeutics's activity chart (see below) currently has 310 price targets and 233 ratings on display. The stock rating distribution of HALO is 70.83% BUY, 8.33% SELL and 20.83% HOLD.
Analysts average stock forecasts to be materialized ratio is 84.91% with an average time for these price targets to be met of 237.79 days.
Highest price target for HALO is $115, Lowest price target is $56, average price target is $78.35.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 02-Sep-2026. First documented stock forecast 12-Jun-2014.
Currently out of the existing stock ratings of HALO, 17 are a BUY (70.83%), 2 are a SELL (8.33%), 5 are a HOLD (20.83%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Jul-2023
$115
$1.1 (0.97%)
$115
29 days ago
(02-Sep-2026)
46/46 (100%)
$5.34 (4.87%)
176
Buy Since 29-Feb-2024
$105
$-8.9 (-7.81%)
$90
1 months 24 days ago
(07-Aug-2026)
9/9 (100%)
$1.88 (1.82%)
187
Buy Since 27-Nov-2018
$93
$-20.9 (-18.35%)
$92
1 months 24 days ago
(07-Aug-2026)
16/17 (94.12%)
$-10.12 (-9.81%)
395
Hold Since 13-Jan-2025
$95
$-18.9 (-16.59%)
$75
1 months 24 days ago
(07-Aug-2026)
9/10 (90%)
$-8.12 (-7.87%)
302
Buy Since 18-Aug-2025
$93
$18.04 (24.07%)
$79
4 months 19 days ago
(12-May-2026)
11/12 (91.67%)
$22.07 (31.12%)
270
What is HALO (Halozyme Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on HALO (Halozyme Therapeutics)?
Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?
Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?
Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?